Worth a listen. Hear how much invested to get to commercialisation versus current Market Cap, but now product being sold in different States in the US and experiencing strong quarter on quarter growth.
Julian Baines MBE, caught up with @brr_mediauk to discuss @Renalytix! 🎥
Find out about what Renalytix do and the only #FDA approved and Medicare reimbursed prognostic test to support early-stage risk assessment for chronic kidney disease.
#RENX
https://t.co/ya2AtItJnj
Good to see Renalytix #RENX break through 10p.
Recent Positive Chairman’s interview
Lots of Directors buying lately
Positive AGM update
Company completely restructured and focused on growth.
I’m looking forward to 2025 with this one.
#RENX are 1st and only FDA approved test for this area of renal disease. They are Medicare reimbursed “This is the most important diagnostic test that I have ever been involved in during my career.” Julian Baines They are showing very positive growth & positive repeat orders!
Well worth watching. Renalytix quoted on AIM. Firmly on the front foot under the leadership of Julian Baines. He has delivered value for shareholders in the past via BBI & EKF.
Rev growth week by week, month by month.
Will not need to come back to Market https://t.co/Ojdp0UYR9b
@BigGibUK@UOGPLC Not for me. I was a foolish bull of this one for far too long in the past. Looks like same old, same old to me. Good luck for anyone else who has a different view.
@SkyNews@BethRigby The man just repeats his answers over and over. Does it on many subjects and occasions. Out of his depth and he and this Government have been a shambles in such a short space of time.